1.
COST-EFFECTIVENESS ANALYSIS OF AVELUMAB TREATMENT FOR PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA. Вопр. онкол. [Internet]. 2020 Feb. 1 [cited 2026 Oct. 14];66(2):109-1. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/1062